Page last updated: 2024-11-11

dykellic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dykellic acid: an apoptosis inhibitor isolated from Westerdykella multispora; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6397984
CHEMBL ID449742
MeSH IDM0360000

Synonyms (5)

Synonym
3-[5-methylidene-2-oxo-6-[(1e,3e)-penta-1,3-dienyl]pyran-3-yl]propanoic acid
CHEMBL449742
dykellic acid
3-(5-methylene-2-oxo-6-((1e,3e)-penta-1,3-dien-1-yl)-5,6-dihydro-2h-pyran-3-yl)propanoic acid
1097679-78-1

Research Excerpts

Overview

Dykellic acid is a novel microbial metabolite isolated from the broth of Westerdykella multispora.

ExcerptReferenceRelevance
"Dykellic acid is a novel microbial metabolite isolated from the broth of Westerdykella multispora F50733. "( Dykellic acid inhibits drug-induced caspase-3-like protease activation.
Kho, YH; Kim, HM; Kim, SU; Lee, HJ; Lee, SH; Youk, ES, 2003
)
3.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID412555Inhibition of recombinant caspase 3 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-DEVD-pNA substrate up to 100 uM2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412559Cytoprotective activity against 20 uM rotenone-induced intracellular ROS production in human U937 cells at 100 uM pretreated for 5 hrs by 2,7-dichlorodihydrofluorescein dye reduction assay2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412556Inhibition of recombinant caspase 6 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-VEID-pNA substrate up to 100 uM2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412558Inhibition of recombinant caspase 8 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-IETD-pNA substrate up to 100 uM2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412554Antiapoptotic activity in human U937 cells assessed as reduction of 1.5 uM etoposide-induced caspase-3/7 like activity at 100 nM pretreated for 5 hrs measured after 24 hrs relative to control2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412551Cytoprotective activity against 50 uM N-methyl-N'-nitro-N-nitrosoguanidine-induced cell death in human U937 cells pretreated for 5 hrs measured after 24 hrs by cell flow cytometry using propidium iodide staining relative to control2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412552Cytoprotective activity against 50 uM H2O2-induced cell death in human U937 cells pretreated for 5 hrs measured after 24 hrs by cell flow cytometry using propidium iodide staining relative to control2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412557Inhibition of recombinant caspase 7 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-DEVD-pNA substrate up to 100 uM2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412549Cytoprotective activity against 5 uM rotenone-induced cell death in human U937 cells pretreated for 5 hrs measured after 24 hrs by cell flow cytometry using propidium iodide staining relative to control2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412765Cytoprotective activity against 20 uM rotenone-induced intracellular ROS production in human U937 cells at 100 uM pretreated for 5 hrs by dihydroethidium dye reduction assay2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
AID412553Antiapoptotic activity in human U937 cells assessed as reduction of 1.5 uM etoposide-induced caspase-3/7 like activity pretreated for 5 hrs measured after 24 hrs relative to control2009Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1
Total synthesis and cytoprotective properties of dykellic acid.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.99 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]